Vir Biotechnology, Inc. - stock earnings
VIR Upcoming estimated earnings
Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
---|---|---|---|---|
May 2, 2024 AfterMarket | -0.48 / -1.06 | - | 56.4 million / 11.8 million | - |
VIR Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2024Q1 | -65.3 million USD | 56.4 million USD |
2023Q4 | -116.0 million USD | 16.8 million USD |
2023Q3 | -163.4 million USD | -4.1 million USD |
2023Q2 | -194.8 million USD | -12.7 million USD |
2023Q1 | -141.0 million USD | 46.7 million USD |
2022Q4 | -101.6 million USD | 21.8 million USD |
2022Q3 | 175.3 million USD | 371.4 million USD |
2022Q2 | -76.5 million USD | -42.7 million USD |
2022Q1 | 518.6 million USD | 1.2 billion USD |
2021Q4 | 525.3 million USD | 809.8 million USD |
2021Q3 | 110.4 million USD | 102.7 million USD |
2021Q2 | 61.8 million USD | 174.0 million USD |
2021Q1 | -168.9 million USD | 605000 USD |
2020Q4 | -105.6 million USD | 301000 USD |
2020Q3 | -84.6 million USD | 188000 USD |
2020Q2 | -31.2 million USD | 66.3 million USD |
2020Q1 | -77.2 million USD | 487000 USD |
2019Q4 | -63.8 million USD | 371000 USD |
2019Q3 | -48.3 million USD | 237000 USD |
2019Q2 | -33.9 million USD | 86000 USD |
2019Q1 | -28.7 million USD | 17000 USD |
2018Q4 | -26.4 million USD | 6000 USD |
2018Q3 | -33.5 million USD | 114000 USD |
2018Q2 | -56.0 million USD | 4.7 million USD |
2018Q1 | -28.0 million USD | 2.3 million USD |
VIR Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -615.1 million USD | 86.2 million USD |
2022 | 515.8 million USD | 1.6 billion USD |
2021 | 528.6 million USD | 1.1 billion USD |
2020 | -298.7 million USD | 76.4 million USD |
2019 | -174.7 million USD | 711000 USD |
2018 | -115.9 million USD | 868000 USD |
2017 | -69.9 million USD | 149000 USD |
VIR
Price: $10.39
52 week price:
Earnings Per Share: -4.59 USD
P/E Ratio: -1.91
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 703157
Market Capitalization: 1.4 billion